Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
27.13
+1.19 (4.59%)
At close: Feb 13, 2026

SHA:688319 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
169.67224.16362.07269.23254.37103.98
Trading Asset Securities
47.617.509020010
Cash & Short-Term Investments
217.27241.66362.07359.23454.37113.98
Cash Growth
-19.37%-33.26%0.79%-20.94%298.63%19.21%
Accounts Receivable
665.08570.35491.55491.69342.52192.26
Other Receivables
2.6211.13.781.10.81
Receivables
667.71571.35492.65495.48343.62193.06
Inventory
68.885.6872.1278.5274.546
Prepaid Expenses
--000.06-
Other Current Assets
10.449.454.352.662.429.71
Total Current Assets
964.22908.14931.19935.89874.98362.76
Property, Plant & Equipment
603.49572.3425.87378.35259.27240.39
Other Intangible Assets
17.2416.3316.8217.5113.7812.22
Long-Term Deferred Tax Assets
22.7218.2114.079.567.11-
Long-Term Deferred Charges
336.73291.5195.76132.3134.9319.74
Other Long-Term Assets
0.580.5628.895.2421.826.15
Total Assets
1,9451,8071,6131,4791,212641.26
Accounts Payable
116.3386.2940.0680.6834.2833.08
Accrued Expenses
0.45368.06346.13321.65251.98167.58
Short-Term Debt
2024.224.2853525
Current Portion of Long-Term Debt
78.787.4231.6910--
Current Income Taxes Payable
9.129.443.749.464.03-
Current Unearned Revenue
2.120.513.626.717.52.56
Other Current Liabilities
405.6719.6726.7911.738.8811.6
Total Current Liabilities
632.39595.59476.22525.23341.66239.83
Long-Term Debt
289.33249.53177.2929.99--
Long-Term Leases
8.650.644.439.043.252.49
Long-Term Unearned Revenue
26.3524.7919.9820.1118.6719.13
Long-Term Deferred Tax Liabilities
8.262.462.722.562.3-
Other Long-Term Liabilities
11.650.531.210.091.332.84
Total Liabilities
976.63873.54681.84587.02367.22264.29
Common Stock
405.93405.93406.16405.27405.27364.74
Additional Paid-In Capital
593.69606605.75580.95570.56251.37
Retained Earnings
-34.22-81.7-87.04-104.59-131.17-239.13
Treasury Stock
-5.56-5.56-7.96---
Total Common Equity
959.85924.68916.91881.63844.66376.97
Minority Interest
8.498.8213.8610.22--
Shareholders' Equity
968.34933.5930.77891.85844.66376.97
Total Liabilities & Equity
1,9451,8071,6131,4791,212641.26
Total Debt
396.68361.79237.61134.0338.2527.49
Net Cash (Debt)
-179.41-120.13124.47225.2416.1186.49
Net Cash Growth
---44.73%-45.88%381.08%0.86%
Net Cash Per Share
-0.44-0.300.310.561.080.24
Filing Date Shares Outstanding
405.93405.93406.16405.27405.27364.74
Total Common Shares Outstanding
405.93405.93406.16405.27405.27364.74
Working Capital
331.83312.55454.97410.67533.31122.93
Book Value Per Share
2.362.282.262.182.081.03
Tangible Book Value
942.6908.35900.08864.11830.88364.75
Tangible Book Value Per Share
2.322.242.222.132.051.00
Buildings
-224.6996.22103.17103.17-
Machinery
-318.26299.39261.88245.29-
Construction In Progress
-211.27181.35135.4911.63-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.